Disc Medicine (IRON) Return on Equity [ROE] (2021 - 2026)
Disc Medicine (IRON) recorded Return on Equity [ROE] of -36.90% in Q2 2026, down 14.09 percentage points from -22.81% a year earlier and down 3.07 percentage points from the prior quarter.
Disc Medicine (IRON) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Disc Medicine reported Return on Equity [ROE] of -35.86%, down 8.13 percentage points from FY2024.
- Annual Return on Equity [ROE] has a three-year change of +47.46 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -27.73% in FY2024 (+1.57 pp), -29.30% in FY2023 (+54.03 pp) and -83.32% in FY2022.
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q4 2022.
- On a year-over-year basis, Return on Equity [ROE] has declined for five consecutive quarters, with an average year-over-year change of -6.09 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 98.25 percentage points in Q4 2023, against a drop of 33.66 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -33.83% (Q1 2026), -32.32% (Q4 2025) and -30.50% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Disc Medicine | 3.27 Bn | 346.87 Mn | - | -39.50% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -39.50% |
| Jun 30, 2026 | -37.19% |
| Mar 31, 2026 | -33.99% |
| Dec 31, 2025 | -32.21% |
| Sep 30, 2025 | -30.51% |
| Jun 30, 2025 | -22.76% |
| Mar 31, 2025 | -21.01% |
| Dec 31, 2024 | -23.93% |
| Sep 30, 2024 | -21.48% |
| Jun 30, 2024 | -22.02% |
| Mar 31, 2024 | -23.59% |
| Dec 31, 2023 | -21.71% |
| Sep 30, 2023 | -17.56% |
| Jun 30, 2023 | -21.89% |
| Mar 31, 2023 | -29.19% |
| Dec 31, 2022 | -119.96% |
| Dec 31, 2021 | -86.30% |
| Sep 30, 2021 | -45.31% |
| Jun 30, 2021 | -30.16% |
| Mar 31, 2021 | -56.09% |
Disc Medicine Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRON&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IRON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();